En español
NIDA

Menu

HIV+ IDUs Are Less Likely to Receive HAART Treatment than Non-IDUs

See text description below

Bar graph illustrating that injection drug users infected with HIV are less likely to be prescribed HAART therapy by health-care providers when they report daily injection drug use as compared to those who report no injection drug use. HIV positive injection drug users with critically low CD4 T cell counts at 200 cells/mm cubed are nearly 30% less likely to receive HAART therapy when they report daily injection drug use as compared to those that report no injection drug use.

Go Back To: How Can HIV Be Prevented and Treated in Drug-Using Populations?